A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes for patients who continue to suffer seizures despite being on multiple medications. Continue Reading Category:Illnesses and conditions, Body and Mind Tags:NYU Langone Health, Pharmaceuticals, Epilepsy, Drug development, clinical trials, Chronic illness
